NRX Pharmaceuticals, Inc.
NRXPWDrugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
NRX Reports Financial Results
Filed: 2026-08-17 AccNo: 0001437749-26-028111 Size: 204 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
SourceNo drugs found in this phase.
Frequently asked questions
When is NRX Pharmaceuticals, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for NRX Pharmaceuticals, Inc. (NRXPW) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track NRXPW biotech catalysts?→
Add NRXPW to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NRX Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.